A novel forehead temperature-regulating device for insomnia: a randomized clinical trial

Area of Science:

• Neurology
• Sleep Medicine
• Medical Devices

Background:

• Insomnia is a prevalent disorder often treated with medications that carry adverse events.
• Novel therapeutic approaches are needed to manage insomnia effectively and safely.

Purpose of the Study:

• To evaluate the safety and efficacy of a forehead temperature-regulating device delivering frontal cerebral thermal therapy for insomnia treatment.

Main Methods:

• A prospective, randomized controlled trial was conducted with 106 adults diagnosed with insomnia.
• The study involved two nights of therapy, measuring latency to persistent sleep and sleep efficiency via polysomnography (PSG).
• Adverse events (AEs) were monitored for frequency and severity.

Main Results:

• The safety profile of the thermal therapy was comparable to sham treatment.
• No statistically significant differences were found in absolute latency to persistent sleep or absolute sleep efficiency.
• Significant improvements were observed in relative changes of sleep latency measures, including latency to stage 1 and 2 NREM sleep, and increased sleep minutes in the first hour.

Conclusions:

• Two-night frontal cerebral thermal therapy demonstrated a benign safety profile in insomnia patients.
• The therapy showed improvements in specific PSG measures related to sleep onset.
• Further research is recommended to establish the long-term role of this therapy in insomnia management.